Basha M, LaBelle EF, Northington GM, Wang T, Wein AJ, Chacko S. Functional significance of muscarinic receptor expression within the proximal and distal rat vagina. Am J Physiol Regul Integr Comp Physiol 297: R1486 -R1493, 2009. First published September 9, 2009 doi:10.1152/ajpregu.90516.2008.-Information regarding the role of cholinergic nerves in mediating vaginal smooth muscle contraction is sparse, and in vitro studies of the effects of muscarinic agonists on vaginal smooth muscle are discrepant. The goal of this study was to determine the expression of muscarinic receptors in the vaginal wall of the rat. In addition, we sought to determine the effect of the muscarinic receptor agonist carbachol on contractility and inositol phosphate production of the proximal and distal rat vaginal muscularis. RT-PCR analysis indicated that both M 2 and M3 receptor transcripts were expressed within the proximal and distal rat vagina. Carbachol dose-dependently (10 Ϫ7 -10 Ϫ4 M) contracted the rat vaginal muscularis with a greater maximal contractile response in the proximal vagina (P Ͻ 0.01) compared with the distal vagina. The contractile responses of the rat vaginal muscularis to carbachol were dose dependently inhibited by the M 3 antagonist para-fluoro-hexahydrosiladefenidol, and a pK B of 7.78 and 7.95 was calculated for the proximal and distal vagina, respectively. Inositol phosphate production was significantly increased in both regions of the vagina following 20-min exposure to 50 M carbachol with higher levels detected in the proximal vagina compared with the distal (P Ͻ 0.05). Preliminary experiments indicated the presence of M 2 and M3 receptors in the human vaginal muscularis as well as contraction of human vaginal muscularis to carbachol, indicating that our animal studies are relevant to human tissue. Our results provide strong evidence for the functional significance of M 3 receptor expression in the vaginal muscularis. vagina; smooth muscle; muscarinic receptor; female sexual response THE VAGINA RECEIVES PARASYMPATHETIC and sympathetic innervation via the pelvic nerves, hypogastric nerves, and sympathetic chain ganglia (17). Although it has been well documented that sympathetic nerves regulate vaginal smooth muscle function, the role of parasympathetic nerves in mediating vaginal smooth muscle contraction has received limited attention. In light of the high prevalence of pelvic organ prolapse (34) and female sexual dysfunction (24) it is essential to develop a more complete understanding of autonomic innervation of the vagina.
THE VAGINA RECEIVES PARASYMPATHETIC and sympathetic innervation via the pelvic nerves, hypogastric nerves, and sympathetic chain ganglia (17) . Although it has been well documented that sympathetic nerves regulate vaginal smooth muscle function, the role of parasympathetic nerves in mediating vaginal smooth muscle contraction has received limited attention. In light of the high prevalence of pelvic organ prolapse (34) and female sexual dysfunction (24) it is essential to develop a more complete understanding of autonomic innervation of the vagina.
In vivo studies of vaginal smooth muscle contraction utilizing pelvic nerve stimulation (PNS) as an animal model of female sexual arousal have provided direct (16) and indirect (27) evidence that the proximal vagina contracts in response to PNS. The distal vagina, however, has been shown to relax in response to PNS (27, 31) , suggesting a regional difference in vaginal smooth muscle function. The majority of in vitro studies of vaginal smooth muscle have investigated signaling pathways responsible for inducing relaxation of the distal vagina (3, 14, 15, 19, 20, 40) . In support of the suggestion that regional differences are present in vaginal smooth muscle responses to PNS, we have provided molecular and functional evidence that the rat proximal vagina is composed of a phasictype smooth muscle compared with a tonic-type smooth muscle in the distal vagina (5) . Together, these studies emphasize the importance of accounting for regional differences in structure and function when studying the vaginal muscularis.
A major pathway of parasympathetic activation of smooth muscle contraction is via interaction of acetylcholine released from cholinergic nerves with muscarinic receptors on muscle cells. Five subtypes of muscarinic receptors (M 1 , M 2 , M 3 , M 4 , M 5 ) have been pharmacologically described and molecularly identified (8) . Although M 2 receptors outnumber M 3 receptors within smooth muscle, pharmacological studies have indicated that M 3 receptor signaling is responsible for the majority of muscarinic agonist-induced smooth muscle contraction of the lower urogenital tract including the bladder (2) and uterus (1, 10, 23) . Recent studies with M 3 receptor knockout mice have provided further evidence that the M 3 receptor plays the predominant role in mediating smooth muscle contraction (25) . Activation of M 3 receptors coupled to G q/11 stimulates calciumdependent smooth muscle contraction through the phosphatidylinositol cascade, which results in the generation of inositol triphosphate (IP 3 ). IP 3 stimulates the release of calcium from intracellular stores and increases myosin light chain-20 phosphorylation, the pivotal event responsible for smooth muscle contraction (33) .
Positive staining for vesicular acetylcholine transporter has been reported in nerve terminals of the rat vaginal muscularis (14, 35) . Cadaveric studies have also demonstrated an abundance of vesicular acetylcholine transporter-positive terminals within the mid-and proximal human vagina (39) . These studies suggest cholinergic nerves may be important in mediating vaginal smooth muscle contraction. However, results from in vitro studies of vaginal contraction in response to the muscarinic agonist carbachol have been conflicting (14, 29, 30, 36) . Intracellular signaling pathways linked to M 3 receptor activation have yet to be explored within the vaginal muscularis.
The objectives of this study were to clarify the significance of parasympathetic innervation of the vaginal wall by determining the effect of muscarinic receptor stimulation on contractile activity and intracellular signaling events linked to M 3 receptor stimulation of vaginal smooth muscle.
MATERIALS AND METHODS

Animal Studies
Animals. Animal use and the experimental protocols were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Virgin, female Sprague-Dawley rats (body wt, 250 -300 g; age, 3-4 mo) were obtained from Charles River Laboratory and housed in a temperature (25°C)-and light-controlled (12:12-h light-dark) room with free access to food and water. The estrus cycle of rats was monitored by cytological evaluation of vagina smears (28) stained with the Protocol Heme 3 stain set (Fisher Scientific, Pittsburgh, PA). Animals were euthanized on the day of estrus by an intraperitoneal injection of an overdose of ketamine (Ͼ75 mg/kg) and xylazine (Ͼ10 mg/kg) followed by exsanguination.
Tissue preparation. The vaginal tube was isolated, dissected from the urogenital tract, cleaned of connective tissue, and cut open longitudinally. The vagina was divided into a proximal (approximately upper two-thirds) and distal segment (approximately lower one-third) under a dissecting microscope as described by Basha et al. (5) . The vaginal segments were either snap frozen in liquid nitrogen and stored at Ϫ80°C or placed in ice-cold MOPS-buffered physiological salt solution (PSS) for same-day physiological studies. The PSS solution contained (in mM): 140 NaCl, 4.7 KCl, 1.2 MgSO 4, 1.6 CaCl2, 1.2 Na2HPO4, 2.0 MOPS, 5.0 D-glucose, and 0.02 Na2-EDTA.
RNA extraction/purification. Next, 50 -100 g of frozen proximal and distal vaginal tissue (n ϭ 3) was ground into a fine powder with a liquid nitrogen-prechilled mortar and pestle. RNA was extracted from the powder using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. RNA concentration was quantified at 260/280 with a UV-visible spectrophotometer (BioSpecmini, Shimadzu, Columbia, MD).
RT-PCR. Three migrograms of RNA were reverse transcribed with oligo(dT) primer (Promega, Madison, WI) and Moloney murine leukemia virus RT (Invitrogen, Carlsbad, CA) at 37°C for 60 min. The reaction was stopped by heating to 90°C and the cDNA was stored at Ϫ20°C. PCR was performed with 1 l of cDNA in a 25 l reaction mixture containing upstream and downstream primer, PCR buffer (Applied Biosystems), dNTP (Roche Applied Science, Germany), and Taq polymerase (Perkin-Elmer, Foster City, CA). Primers for rat M 2 and M3 receptors were based on sequences published by Borges et al. (7) .
Isometric force measurements. DETERMINATION OF pEC50 AND MAXIMAL RESPONSE OF PROXIMAL AND DISTAL STRIPS. Longitudinal strips of proximal and distal rat vagina obtained from four animals were mounted between a force transducer (Grass model FT.03) and a stationary clip and immersed in water-jacketed organ baths containing PSS (37°C, aerated with 100% O 2). Strips were equilibrated for 90 min, during which time they were repeatedly contracted by the addition of 110 mM KCl (equimolar substitution for NaCl) to the organ bath. Between contractions, the strips were stretched until the length that approximates the optimal length for maximal active contraction (L 0) was reached. Carbachol was added to organ baths in a noncumulative manner to achieve bath concentrations of 10 Ϫ7 -10 Ϫ4 M. Each drug addition was washed out of the tissue preparation by repeated washes (3ϫ15 min) with PSS. Force in response to carbachol was expressed as a %maximal KCl force development and a sigmoid concentration response curve was constructed using Graph Pad Prism (version 5.02).
DETERMINATION OF pKB OF p-F-HHSiD. For studies with the antagonist, para-fluoro-hexahydrosiladefenidol (p-F-HHSiD), longitudinal strips of proximal and distal rat vagina were mounted, equilibrated, and stretched to L 0 as described above. Carbachol was added to organ baths in a cumulative manner to achieve bath concentrations of 10 Ϫ7 -10 Ϫ3.5 to construct a control dose response curve for each strip. Following a 45-min washout period with PSS, each strip was incubated for 20 min in either antagonist or vehicle (time control) and then underwent a second series of cumulative additions of carbachol. Three concentrations of antagonist (30 nM, 100 nM, 300 nM) and timecontrol studies were tested in separate strips obtained from three to six animals. A sigmoid dose-response curve to carbachol was constructed in the absence (control curve) and presence of antagonist with force normalized to the maximum response of the control curve. The concentration ratio (CR) for each concentration of antagonist was calculated by determining the EC 50 in the presence and absence of antagonist for each strip.
Inositol phosphate measurements. Segments of rat vagina, either proximal or distal (n ϭ 4 animals), were preincubated for 1 h in 2 ml PSS solution at 37°C. The PSS was aerated with 95% O 2-5% CO2 until the pH equaled 7.4. After preincubation, the segments were incubated for 1 h in fresh PSS containing [ 3 H]-labeled inositol (10 Ci/ml) and then treated for 30 min with LiCl (10 mM). The tissues were then treated with 50 M carbachol for periods of between 2 and 20 min, placed on small pieces of filter paper, and immersed in liquid N 2. The frozen segments were thawed in 2-ml cold trichloroacetic acid solution (10% wt/vol). The trichloroacetic acid solutions were extracted four times with 2 ml ethyl ether (4°C) to remove the trichloroacetate. The inositol phosphates were then separated from each other and from free inositol by the procedure of LaBelle and Murray (22) . Solutions containing inositol phosphates were applied to columns of Dowex model 1X8-400 (200 -400 mesh) resin (0.5 ml) and washed with 12 ml water to remove the free inositol. The columns were then treated sequentially with 5 ml of 0.2 M, 0.4 M, and 0.8 M ammonium formate/0.1 M formic acid to elute inositol monophosphate (IP1), inositol bisphosphate (IP2), and inositol triphosphate (IP3), respectively. Aliquots (2.5 ml) of each step were added to scintillation fluid (16 ml Ecolume), and the radioactivity in the samples determined using a Beckman scintillation counter.
Human Studies
Human tissue. Following approval of our protocol by the University of Pennsylvania Institutional Review Board, women scheduled to undergo hysterectomy for benign indications (leiomyoma, adenomyosis, or pelvic organ prolapse) were recruited to participate in an ongoing study of human vaginal smooth muscle. Patients with gynecological malignancy, connective tissue disorders, prior surgery for pelvic organ prolapse, or any neuromuscular disorder were excluded. Following written informed consent, hysterectomy was performed in a standardized fashion, and a full thickness vaginal biopsy (posterior) was obtained immediately after removal of the uterus and cervix. Each full-thickness biopsy was ϳ1-2 cm (width) ϫ 1 cm (depth) and taken from the central portion of the posterior vaginal cuff as previously described (6) .
Tissue preparation. Immediately after surgical excision, biopsies were immersed and stored in Tyrode's buffer (in mM: 125 NaCl, 2.7 KCl, 23.8 NaHCO3, 0.5 MgCl2 ⅐ 6 H2O, 0.4 NaH2PO4 ⅐ H2O, 1.8 CaCl2, and 5.5 dextrose) at 4°C to be used later the same day. For the physiology experiments (n ϭ 1) and molecular studies (n ϭ 3), the vaginal muscularis was dissected from biopsy samples within 2 h of excision with the aid of a dissecting microscope. The remainder of the muscularis tissue from the sample used in physiology and all of the muscularis tissue from the other patients (n ϭ 3) was snap frozen in liquid nitrogen and stored at Ϫ80°C for subsequent molecular studies.
RNA extraction/purification. RNA was extracted from frozen pulverized vaginal muscularis samples using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. To increase RNA yield, 200 g of glycogen was added to each sample, and the mixture was passed two times through a 26-gauge needle (to shear genomic DNA) prior to centrifugation at 12,000 g ϫ 10 min in 4°C.
RNA concentration was measured at 260/280 wavelengths with a UV-visible spectrophotometer (BiosSpec-mini, Shimadzu).
RT-PCR. Three micrograms of RNA underwent RT-PCR as described in the Animal Studies. RT-PCR of mRNA transcripts for M 2 and M3 receptors was performed using primers based on the sequences published by Wang et al. (37) .
Isometric force measurements. Longitudinal vaginal muscularis strips (ϳ3 mm ϫ 10 mm, ϳ80 -120 mg) were suspended in 15 ml of Tyrode's buffer at 37°C and equilibrated with 95% oxygen-5% CO 2. One end of each muscle strip was attached to a glass rod that was immersed in Tyrode's buffer, and the other end was attached to a force transducer. After a 45-min incubation period, the length of optimal force development (L 0) was determined by increasing the length of each strip in ϳ1.5-mm increments until maximal contractile force to a high-KCl solution (125 mM) was achieved. Contractile responses were recorded in response to the cumulative addition of carbachol (10 Ϫ5 -10 Ϫ3 M).
Statistics
All statistics were performed using the Systat Statistical software program (version 3.5). pEC 50 and maximal response to carbachol were compared using paired t-tests. Generation of inositol phosphates (IP 1, IP2, IP3) in response to carbachol were compared using repeatedmeasures two-way ANOVA. Significant factors (␣ ϭ 0.05) underwent post hoc analysis using a Student-Neumen-Keuls test.
RESULTS
RT-PCR analysis indicated that both M 2 and M 3 receptor transcripts were present in the proximal and distal rat vaginal wall (Fig. 1) . Noncumulative addition of carbachol (10 Ϫ7 -10 Ϫ4 M) contracted the proximal and distal vagina in a concentration-dependent manner, indicating a functional significance of muscarinic receptor transcript expression in the vaginal wall (Fig. 2) . The calculated pEC 50 of the proximal vagina was not significantly different than the distal vagina with an overall mean pEC 50 of 5.70 Ϯ 0.20. However, the maximal force of contraction of the proximal vagina expressed as a percentage of KCl contraction (172.77 Ϯ 8.83%) was greater (P Ͻ 0.01) than that of the distal vagina (113.62 Ϯ 8.27%).
To examine the significance of M 3 receptor expression within the vagina, we evaluated the effects of the selective M 3 antagonist, p-F-HHSiD on carbachol-induced contractions. Time-control experiments indicated that the pEC 50 and maximal response to cumulative addition of carbachol were not significantly different between two consecutive curves for both the proximal and distal vagina (n ϭ 4). Incubation of strips in p-F-HHSiD (n ϭ 4 -7 strips from different animals) dose dependently antagonized carbachol-induced contractions and resulted in parallel rightward shifts of the concentration-response curves for both the proximal (Fig. 3A) and distal vagina (Fig. 3B) . CRs at each concentration of antagonist were utilized to construct a Schild plot to determine the affinity estimate of p-F-HHSiD (4). The slope of the linear regression of log (CR-1) and log [antagonist] did not deviate significantly from unity for both proximal (0.99 Ϯ 0.26) and distal (0.82 Ϯ 0.16) strips, and therefore the slopes of the lines were constrained to 1. The x-axis intercept of the line estimated a pK B of 7.78 (95% CI, 8.96 -7.41 range) and 7.95 (95% CI, 8.74 -7.61 range) for p-F-HHSiD within the proximal and distal vagina, respectively (Fig. 3C) .
In experiments with a separate group of animals (n ϭ 4), incubation of strips in 50 M carbachol resulted in a significant increase of IP 1 , IP 2 , and IP 3 (Fig. 4, A, B , and C, respectively) at both 10-and 20-min incubation compared with basal levels for proximal strips (P Ͻ 0.001) and at 20-min incubation for distal strips (P Ͻ 0.05). Significantly greater amounts of IP 1 , IP 2 , and IP 3 were detected in proximal vaginal strips compared with distal vaginal strips at both 10 and 20 min of carbachol stimulation (P Ͻ 0.01).
Vaginal muscularis from three patients undergoing hysterectomy were included to demonstrate the presence of the M 2 and M 3 receptor mRNA. Patient demographics are shown in Table 1 . All samples were used for molecular and physiologic analyses. Results of RT-PCR indicated that M 2 and M 3 recep- . Carbachol-stimulated force was expressed as a percentage of maximal 110 mM KCl stimulated contraction. The pEC50 was not significantly (ns) different between proximal and distal strips, whereas the maximum contractile response of proximal strips was significantly greater (P Ͻ 0.01) than that of the distal strips. Each point represents the mean Ϯ SD (n ϭ 4 animals).
tor transcripts were expressed within human vaginal muscularis obtained from biopsies taken from the vaginal cuff (Fig. 5A) . Preliminary functional studies detected a dose-dependent contractile response of human vaginal muscularis to the cumulative addition of carbachol with an pEC 50 of 3.99 (Fig. 5B ).
DISCUSSION
Our study is the first report of M 2 and M 3 receptor transcript expression in the rat and human vagina (Figs. 1 and 5A ). In addition, we show that the muscarinic agonist carbachol stimulates contraction of both the rat and human vagina with a concomitant increase in inositol phosphate production in the rat vaginal wall. These results suggest that parasympathetic innervation of the vaginal wall plays a significant role in mediating vaginal smooth muscle contraction.
Carbachol (10
Ϫ7 -10 Ϫ4 M) contracted both the proximal and distal rat vagina in a concentration-dependent manner (Fig. 2) . Our animal studies indicated that the calculated pEC 50 for carbachol-induced contraction was not significantly different between the proximal and distal vagina, suggesting a similar receptor affinity in both regions of the vagina. Our reported overall mean pEC 50 of 5.70 Ϯ 0.20 is similar to values reported for carbachol-induced contractions of the rat uterus (10) and female rat bladder (21) . In contrast, the maximal contractile response of the proximal vagina was ϳ1.5 times greater than that of the distal vagina. As we expressed the amplitude of carbachol-induced contraction as a percentage of KCl contraction, this difference is not due to the greater amount of muscle within the proximal vagina compared with the distal vagina (5) and may suggest either a greater number of muscarinic recep- In general, results of previous studies examining vaginal responses to carbachol have been mixed and contradictory. Several in vitro studies of vaginal contractility have reported a lack of carbachol-induced force of both the proximal and distal vagina of the rabbit (29), the mid and proximal human vagina (36) and the proximal and distal rat vagina (30) , despite utilizing similar ranges of agonist concentration as that used in the present study. Species differences and differences in strip preparation may explain why others have failed to detect a contractile response of vaginal strips to carbachol. Most relevant for comparison to this study, Onol et al. (30) utilized circular vaginal strips of the rat and did not control for the stage of estrus cycle, compared with our study, utilizing longitudinal strips taken from rats at the estrus stage of their cycle.
Giraldi et al. (14) , on the other hand, demonstrated that carbachol dose dependently contracted the distal vaginal smooth muscle of the rat in agreement with the present study. In contrast to our study, these researchers were unable to detect a contractile response of the proximal vagina to KCl stimulation. This discrepancy is likely due to differences in stretching protocols. Whereas we have estimated L 0 by repeated contractions of KCl following successive stretches until developed tension was maximal, Giraldi et al. (14) prestretched proximal and distal strips to the same predetermined passive tension of 4 -5 mN. It is possible that this stretching protocol may have resulted in a resting length of the proximal vagina that is not within the range of L 0 .
We detected carbachol-induced contraction of the human vaginal muscularis in response to 10 Ϫ5 -10 Ϫ3 M carbachol (Fig. 5B) and mRNA transcripts for M2 and M3 receptors (Fig.  5A) , suggesting that the results of our animal studies are relevant to the human. We acknowledge that as we were only able to obtain viable tissue from a single biopsy taken from the vaginal cuff of a patient undergoing surgery for uterovaginal prolapse to date, and therefore this result is preliminary. We did not detect contraction in response to doses Ͻ 10 M and calculated a pEC 50 of 3.991, which is considerably lower than the mean pEC 50 for carbachol utilizing rat vaginal strips. This may represent a species difference in sensitivity to carbachol. It is also possible that the decreased sensitivity of the human vaginal muscularis to carbachol is due to compromised contractile function of the vaginal muscularis due to prolapse, tissue damage during biopsy collection, and time lapse be- tween biopsy collection and physiological experiments. The influence of biopsy collection procedures and tissue storage may also explain the failure of Uckert et al. (36) to detect a contractile response to carbachol of the human vaginal muscularis. Both our study and the study of Uckert et al. (36) utilized strips taken from menopausal patients. As there is evidence from animal studies that estrogen alters carbacholinduced contraction of bladder smooth muscle, it is also possible that menopausal status influences vaginal smooth muscle responses to carbachol. Studies are needed to examine the possible effect of prolonged ovarian hormone loss on muscarinic receptor-mediated vaginal smooth muscle contraction. Our finding that carbachol-induced force was dose dependently inhibited by p-F-HHSiD lends further support that muscarinic receptors regulate vaginal smooth muscle contraction. Our calculated pK B values of 7.78 and 7.95 for p-FHHSiD obtained with strips taken from the proximal and distal vagina, respectively, are within the range of potencies (7.5-7.9) previously reported for p-F-HHSiD at the M 3 receptor (for a review, see Ref. 11 ). This finding is consistent with studies on nonvascular smooth muscles that indicate contraction is mediated predominantly via M 3 receptor stimulation (1, 9, 10, 18, 23, 38) .
Given the considerable discrepancy in results of in vitro contractile studies of the vaginal wall, and to assist in clarification of the role of muscarinic receptors in mediating contraction of vaginal smooth muscle, we examined the effect of carbachol stimulation on inositol phosphate production of the proximal and distal vagina. It has been widely accepted that M 3 receptors couple to G q/11 to activate PLC and generate IP 3 leading to calcium-dependent smooth muscle contraction. Results of inositol phosphate production in response to 50 M carbachol indicated that the contractile effects of muscarinic receptor activation may be at least partially attributed to the generation of IP 3 . Significant increases in IP 3 and its breakdown products, IP 2 and IP 1 , were measured in proximal and distal rat vaginal strips following incubation with carbachol (Fig. 4) . In addition, our report of significantly greater levels of inositol phosphate production by the proximal vagina compared with the distal vagina is consistent with our finding of a greater maximal contractile response of the proximal vagina compared with the distal vagina. As it has been previously reported that PLC activity, and inositol phosphate production in response to carbachol stimulation are increased during gestation and 17␤-estradiol within the rat myometrium, it would be interesting to investigate the possibility of estrogen regulation of intracellular signaling pathways linked to M 3 receptor activation within the vaginal muscularis.
It should be noted, however, that there have been controversial findings indicating that the PLC-IP 3 pathway may not be important in mediating rat urinary bladder contraction based on studies using the PLC inhibitor, U73122 (12, 32) . Conversely, Frei et al. (13) have recently demonstrated that U73122 inhibited carbachol-induced contractions and calcium signals in the mouse bladder. However, the results suggest that PLC/IP 3 -mediated calcium release makes only a minor contribution to muscle contraction, with calcium entry through L-type calcium channels playing a bigger role in M 3 -mediated contraction. These results may be tissue-and species-specific, as McCarron et al. (26) demonstrated that blocking the IP 3 receptor resulted in ϳ70% reduction in amplitude of carbachol-induced contractions of the guinea pig distal colon.
The majority of in vitro and in vivo studies of the vagina have been aimed at identifying mechanisms responsible for distal vaginal relaxation that is reported to occur during the arousal phase of the female sexual response. The results of our present study, in conjunction with our previous report that the proximal vagina is structurally and functionally distinct from the distal vagina (5), suggest that results obtained using the distal vagina cannot be extrapolated to the proximal vagina. Indeed, studies utilizing rodent models of female sexual arousal have indicated that the proximal vagina contracts in response to PNS, as opposed to relaxation of the distal vagina, providing in vivo evidence that the proximal and distal vagina play distinct roles in the female sexual response. Lastly, the finding that proximal vaginal contractions induced by PNS were blocked by the muscarinic antagonist atropine (16) is in support of our evidence of a functional significance of muscarinic receptor expression in the rat and human vaginal wall.
Perspectives and Significance
Although autonomic regulation of the male sexual response has been well studied, little is known regarding the neural regulation of the female sexual response. Our study provides convincing evidence that muscarinic receptor activation contracts vaginal smooth muscle and suggests that the vaginal component of the female sexual response may be mediated in part by parasympathetic nerves. As we have shown regional differences in vaginal responses to carbachol, we also provide further evidence that the separate embryological origins of the proximal and distal vagina may result in distinct functional roles of these two regions of the vagina. Research is needed to more completely determine the vaginal changes that occur during the female sexual response and to identify the intracellular signaling cascades responsible for mediating these changes.
